German and Swiss start-ups are again successful at European Health Catapult competition during EIT Health Summit
The European Health Catapult Competition reached its climax on 5 December at the EIT Health Summit in London, where a jury of experts announced the winning start-ups in the Medtech, Biotech and Digital Health categories. German and Swiss start-ups were again very successful during the competition.
After the pre-selections of the semi-finals, where 6 German and Swiss start-ups have been successful (SUN Bioscience, Elthera AG, Lumobiotics, Enmodes, SpinDiag and Viomedo), German and Swiss start-ups have been again successful in the European Health Catapult competition at the EIT Health Summit on 4-5 December 2017 in London. SUN Biosciene received the first award and Elthera AG won the third award in the biotech category. Enmodes received the first award in the Medtech Category.
Following a year of training and competition, the top 21 of the original 42 start-ups that were accepted for the prograrmme competed for cash awards and the attention of potential investors at the EIT Health Summit in the European Health Catapult finals. They were each allowed to give a brief pitch of their innovation and the jury, chosen from EIT Health’s partnership, determined which ideas showed the most promise to become commercially successful and improve healthcare. The winning start-ups chosen by the jury are:
1st prize: Enmodes – provides design and engineering services to medical device companies with a major focus on validated computational analyses and optimization.
2nd prize: Mowoot by Usmima – Reproduces the abdominal massage performed by physiotherapists to facilitate intestinal transit, the solution to chronic constipation that improves its effectiveness over time.
3rd prize: Oxford Endovascular Limited – Developing metallic mesh tube devices invented by engineers and clinicians at Oxford University to treat patients suffering from brain aneurysms.
1st prize: SUN Bioscience – Their Gri3D platform allows creation of a 3D culture to produce organoids, a development that allows scientists to derive stem cells that are unique to each patient, thereby opening the door to personalised drug testing and regenerative medicine.
2nd prize: LifeTag – Focused on Research & Development of non-invasive technologies for evaluating metabolism and improving the diagnosis of chronic metabolic diseases, such as Type-2 diabetes and non-alcoholic fatty liver disease.
3rd prize: Elthera – Brings together experienced pharma and biotech executives with cutting-edge academic researchers to develop proprietary, first-in-class oncology drugs using a personalized health care approach.
1st prize: FibriCheck by Quompium – A medically certified application for the detection of irregular heart rhythms, including atrial fibrillation, only requires the user to place their finger on the camera of the smartphone to measure cardiac rhythm and share the measurments automatically with a medical professional.
2nd prize: Complex Disease Detector by Hippogriff – An accurate, non-invasive and affordable technology for screening and early diagnosis of heart disease uses a person’s usual medical data including ECG and demographic data, analysed with artificial intelligence, to offer a great decision support tool to doctors and help them detect heart disease before it gets late.
3rd prize: Advantis – Their innovation, Brainance™, is a web-based post-processing and 3D Vizulasiation MRI software that provides a wide range of modules for the processing of brain MRI exams.
“The quality and maturity of our 21 finalist from all over Europe was impressive.”
“The final in London of our first European Health Catapult together with Health Axis Europe was a great success,” said Kurt Höller, EIT Health Director Of Business Creation and head of the Accelerator pillar, which ran the programme. “The newly introduced semifinal days with additional coaching paid off completely. The quality and maturity of our 21 finalist from all over Europe was impressive. The jury had a really hard time to pick the overall winners after all these impressive pitches. Nevertheless, I’m very happy that Bieke, Sylke and Tim made it to the top. Not only were their companies providing innovative products in each category, the three CEOs were also personally convicing as truly inspiring entrepreneurs!”
The day before the jury made its selection, all the attendees of the EIT Health Summit had a chance to listen to the pitches from the start-ups in the European Health Catapult and to vote on their favorites. In that competetition Mowoot, which was chosen number two in the medtech category by the jury, won the most votes from the general audience.
The other winners of the Public Awards were:
In biotech: Affichem – A company whose mission is to design, develop and market innovative therapeutic molecules and theranostic markers for the treatment of cancer and neurodegenerative diseases.
In digital health: BloodLink – which streamlines the sourcing and exchange of blood, and reduces blood shortages, by connecting all stakeholders on one online platform, which provides a safe, secure and cost efficient way for blood banks and hospitals to find and exchange blood across the nation.
The European Health Catapult is a training and competition platform, organized by EIT Health together with the Health Axis Europe (HAE), to support start-ups or young SMEs in medtech, biotech and digital health. Participating companies had the possibility to mature their business plan, negotiation and pitching skills – and to learn from experts during a three-day training with other start-ups from all over Europe.